Biomind Labs Inc. (BMNDF)
USD 0.7
(150.27%)
USD 0.7
(150.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -15.42 Thousand USD | 63.7% |
| 2022 | -42.48 Thousand USD | -51.36% |
| 2021 | -28.07 Thousand USD | -1184.37% |
| 2020 | 2588.70 USD | -87.63% |
| 2019 | 20.92 Thousand USD | -94.82% |
| 2018 | 403.74 Thousand USD | -57.89% |
| 2017 | 958.68 Thousand USD | 195.84% |
| 2016 | 324.05 Thousand USD | -24.36% |
| 2015 | 428.38 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2220.04 USD | 0.0% |
| 2024 Q2 | -2229.54 USD | -0.43% |
| 2023 Q2 | -2259.44 USD | 52.62% |
| 2023 Q3 | -2201.68 USD | 2.56% |
| 2023 Q4 | - USD | 100.0% |
| 2023 Q1 | -4768.36 USD | 54.07% |
| 2023 FY | -15.42 Thousand USD | 63.7% |
| 2022 Q1 | -8990.07 USD | 0.64% |
| 2022 FY | -42.48 Thousand USD | -51.36% |
| 2022 Q4 | -10.38 Thousand USD | -0.82% |
| 2022 Q3 | -10.29 Thousand USD | 10.89% |
| 2022 Q2 | -11.55 Thousand USD | -28.54% |
| 2021 Q1 | 3.18 USD | 0.0% |
| 2021 Q4 | -9048.43 USD | -2.58% |
| 2021 Q2 | -57.34 USD | -1901.59% |
| 2021 Q3 | -8820.54 USD | -15283.76% |
| 2021 FY | -28.07 Thousand USD | -1184.37% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 2588.70 USD | -87.63% |
| 2019 FY | 20.92 Thousand USD | -94.82% |
| 2018 FY | 403.74 Thousand USD | -57.89% |
| 2017 FY | 958.68 Thousand USD | 195.84% |
| 2016 FY | 324.05 Thousand USD | -24.36% |
| 2015 FY | 428.38 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -532.39% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.132% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 95.173% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.013% |
| Qrons Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.94% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 68.039% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 87.586% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.103% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 597.228% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.157% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 123.466% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 54.835% |
| Mesoblast Limited | -35.16 Million USD | 99.956% |
| Marizyme, Inc. | 457.7 Thousand USD | 103.37% |
| Genus plc | 178.7 Million USD | 100.009% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.007% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 124.787% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 103.76% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -40.218% |
| ContraFect Corporation | -154 Thousand USD | 89.984% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 69.152% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 120.094% |
| IMV Inc. | -962.29 Thousand USD | 98.397% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 96.02% |
| MultiCell Technologies, Inc. | 49.32 USD | 31373.317% |
| ONE Bio Corp. | 20.12 Million USD | 100.077% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.038% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 131.542% |
| Q BioMed Inc. | -8988.00 USD | -71.607% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.055% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.035% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 98.649% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 122.034% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -211.47% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 110.978% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 84.183% |
| GB Sciences, Inc. | -624.00 USD | -2371.795% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 82.071% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.0% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -7315.385% |
| Enzolytics Inc. | 30.7 Thousand USD | 150.228% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 103.197% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.001% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 97.002% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 102.498% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.004% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -74.164% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 81.605% |
| Kadimastem Ltd | -630.13 Thousand USD | 97.552% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 101.561% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.16% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.1% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -30.325% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 108.736% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 108.736% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 101.137% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 46.814% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 103.427% |
| SYBLEU INC | 11.69 Thousand USD | 231.874% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 100.335% |
| Bioxytran, Inc. | -8285.00 USD | -86.168% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 95.865% |
| Neutra Corp. | 14.33 Thousand USD | 207.597% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 81.19% |
| PureTech Health plc | -1.6 Million USD | 99.038% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 98.46% |
| IXICO plc | 3.27 Million USD | 100.472% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 97.778% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 99.139% |
| CSL Limited | 7.7 Billion USD | 100.0% |
| Cellectis S.A. | 18 Thousand USD | 185.689% |